How to profit from advances in genetic medicine
The pharma industry has not always been kind to the most innovative of companies. But regulation is changing alongside a rising demand for targeted personalised therapies. Pharma companies are beginning to invest in the genetic medicines market, but this European giant is leading the way.
Human evolution naturally takes place over thousands of years. That is why – fashion and hygiene aside – modern humans look very like (and are nearly genetically identical to) the humble homo sapiens which roamed the earth over one million years ago.
It’s true that evolutionary changes have taken place in that time – for example, today’s humans rarely develop a third set of molars and most produce the enzyme which allows them to digest milk. But those changes have been slow and gradual. Modern science is increasing the pace at which we can make permanent changes to human DNA. Today,…
Continue reading this article…
- In depth coverage of many of the world’s great companies
- Breaking news on potential upcoming disasters
- Unique insights from our top research team
- Only pay for what you want to read
- Easy credit payment system
- Access our excellent Premium content
Previous article Next article